Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, November 27, 2018

Public edition |

Newswise Cancer Research Wire for 27-Nov-2018

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Reliance on “YouTube Medicine” May Be Dangerous for Those Concerned About Prostate Cancer

The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows.

– NYU Langone Health

European Urology

Embargo expired on 27-Nov-2018 at 00:05 ET

Study Identifies a Genetic Driver of Deadly Prostate Cancer

A new study has identified a novel molecular driver of lethal prostate cancer, along with a molecule that could be used to attack it. The findings were made in laboratory mice. If confirmed in humans, they could lead to more effective ways to control...

– Cedars-Sinai

Nature Medicine, Nov-2018

Embargo expired on 26-Nov-2018 at 11:00 ET

Johns Hopkins Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer gro...

– Johns Hopkins Medicine

Molecular Oncology; P30CA006973

CAR T Studies Highlight Abramson Cancer Center Research at ASH Annual Meeting

Penn researchers will present findings at the 60th American Society of Hematology Annual Meeting and Exposition in San Diego, including studies that evaluate CAR T combinations, how the timing of CAR T therapy may impact its effectiveness, and which ...

– Perelman School of Medicine at the University of Pennsylvania

60th American Society of Hematology Annual Meeting and Exposition

Fred Hutch at ASH: Press briefing on a combination CAR T-cell therapy, other CAR T insights, CRISPR for blood disorders, and more

Fred Hutchinson Cancer Research Center’s latest findings on cancer immunotherapies, CRISPR for blood disorders, stem cell transplantation and insights on the immune system and cancer will be featured at the 60th annual meeting of the American Socie...

– Fred Hutchinson Cancer Research Center

ASH Annual Meeting

Research Review Underscores Progress in Treating Kidney Cancer, Importance of Close Patient Monitoring

In an effort to compile and summarize the latest knowledge about these immunotherapy combinations and their implications, a group of kidney cancer immunotherapy experts led by Saby George, MD, of Roswell Park Comprehensive Cancer Center have written ...

– Roswell Park Comprehensive Cancer Center

JAMA Oncology

Enzyme Discovery Points Researchers Toward Starving Lung Cancer as a Potential Treatment

UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.

– UT Southwestern Medical Center

Cell Reports

Time for Young Men to Get Smart About Testicular Cancer

In November, some men grow mustaches to bring attention to men’s health issues. It’s also a good time for young men to learn about testicular cancer, the cancer that is most likely to strike them in the prime of life.

– UT Southwestern Medical Center


CDC awards the College of American Pathologists five-year cancer reporting grant

The Centers for Disease Control and Prevention (CDC) awarded the College of American Pathologists (CAP) a five-year, $300,000/year collaborative grant to further address standardization and support for diagnostic cancer and biomarker electronic repor...

– College of American Pathologists (CAP)

Two Loyola Physicians Honored at Stritch Awards Dinner

Loyola University Chicago Stritch School of Medicine bestowed its highest honor, the Stritch Medal, to Kathy Albain, MD. Eva Bading, MD, received the AMDG award in recognition of her decades of service to medically underserved communities.

– Loyola University Health System

Peers choose MD Anderson’s Gershenwald, Hwu as new AAAS Fellows

Two leaders in the field of melanoma treatment – a surgeon and an oncologist – from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS).

– University of Texas M. D. Anderson Cancer Center

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

– University of California San Diego Health

Jefferson Lab Shares 2018 R&D 100 Award for Cancer Treatment Monitoring System

The OARtrac® system, built by RadiaDyne and including technologies developed by scientists at the U.S. Department of Energy's Thomas Jefferson National Accelerator Facility, has been awarded a 2018 R&D 100 Award by R&D Magazine.

– Thomas Jefferson National Accelerator Facility

Expert Pitch

UCLA health expert available to comment on FDA approval of targeted cancer therapy, larotrectinib, for patients with a wide variety of cancers.

– University of California, Los Angeles (UCLA), Health Sciences





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 UT Southwestern Medical Center

 University of California San Diego Health

 Thomas Jefferson National Accelerator Facility

 University of California, Los Angeles (UCLA), Health Sciences

 College of American Pathologists (CAP)

 University of Texas M. D. Anderson Cancer Center

Subscribe / Unsubscribe
Edit my preferences

© 2018 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us